Skip to main content

Peer Review reports

From: Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma

Original Submission
4 Aug 2021 Submitted Original manuscript
15 Sep 2021 Author responded Author comments - Hongzhi Wang
Resubmission - Version 2
15 Sep 2021 Submitted Manuscript version 2
5 Jan 2022 Reviewed Reviewer Report
1 Mar 2022 Reviewed Reviewer Report
19 Apr 2022 Author responded Author comments - Hongzhi Wang
Resubmission - Version 3
19 Apr 2022 Submitted Manuscript version 3
6 May 2022 Reviewed Reviewer Report
11 Jun 2022 Author responded Author comments - Hongzhi Wang
Resubmission - Version 4
11 Jun 2022 Submitted Manuscript version 4
Publishing
24 Jun 2022 Editorially accepted
15 Jul 2022 Article published 10.1186/s12885-022-09819-3

You can find further information about peer review here.

Back to article page